Werewolf Therapeutics Inc
NASDAQ:HOWL
Werewolf Therapeutics Inc
NASDAQ:HOWL
Price:
0.8702
USD
7.3%
Market Cap:
$42.2m
Relative Value
The Relative Value of one
HOWL
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 0.8702 USD,
Werewolf Therapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HOWL Relative Value
HIDDEN
Multiples Across Competitors
HOWL Competitors Multiples
Werewolf Therapeutics Inc Competitors
Werewolf Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Werewolf Therapeutics Inc
NASDAQ:HOWL
|
41.1m USD | 0 | -0.6 | 0 | 0 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.3B USD | 6.1 | 89.4 | 14.8 | 20.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
194.6B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
176B USD | 6 | 20.8 | 13 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.8B USD | 9.6 | 29.3 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.6B USD | 5.5 | 17.5 | 13 | 14.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD | 3.1 | 34.1 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36.7B EUR | 10.4 | 33.5 | 36.3 | 37 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
